Scorpius Holdings, Inc. (SCPX)

NYSEAMERICAN: SCPX · Real-Time Price · USD
0.340
-0.042 (-11.03%)
At close: Dec 20, 2024, 4:00 PM
0.330
-0.010 (-2.83%)
After-hours: Dec 20, 2024, 7:49 PM EST
-11.03%
Market Cap 1.47M
Revenue (ttm) 10.04M
Net Income (ttm) -28.81M
Shares Out 4.33M
EPS (ttm) -14.96
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 662,489
Open 0.330
Previous Close 0.382
Day's Range 0.288 - 0.360
52-Week Range 0.280 - 110.000
Beta -0.35
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About SCPX

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company ... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Jul 24, 2013
Employees 84
Stock Exchange NYSEAMERICAN
Ticker Symbol SCPX
Full Company Profile

Financial Performance

In 2023, Scorpius Holdings's revenue was $6.99 million, an increase of 1789.60% compared to the previous year's $370,176. Losses were -$45.22 million, 4.10% more than in 2022.

Financial Statements

News

Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model

New business unit offers services for promising biotech companies through combined fee-for-service and equity-based model, fostering partnerships that align with BIOSECURE Act goals to onshore and str...

4 weeks ago - GlobeNewsWire

Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability

DURHAM, N.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), ...

5 weeks ago - GlobeNewsWire

Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement

DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), ...

6 weeks ago - GlobeNewsWire

Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually

DURHAM, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated biomanufacturing company, today announced the implementation o...

7 weeks ago - GlobeNewsWire

Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA

Collaboration Aims to Expedite the Development of Critical Solutions for Public Health Threats, Including Pandemic Preparedness and Emerging Infectious Diseases Collaboration Aims to Expedite the Deve...

3 months ago - GlobeNewsWire

Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow

DURHAM, N.C., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), ...

4 months ago - GlobeNewsWire

Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024

Reduces operating expenses by 25% Pipeline surpasses $100 million in weighted opportunities across the government and manufacturing sectors DURHAM, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Scorpius Hol...

4 months ago - GlobeNewsWire

Scorpius Holdings, Inc. Announces Closing of Public Offering

DURHAM, N.C., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius”, or the “Company”), an integrated contract development and manufacturing organization (CDMO),...

4 months ago - GlobeNewsWire

Scorpius Holdings, Inc. Announces Pricing of Public Offering

DURHAM, N.C., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius”, or the “Company”), an integrated contract development and manufacturing organization (CDMO),...

4 months ago - GlobeNewsWire

Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering

DURHAM, N.C., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius”, or the “Company”), an integrated contract development and manufacturing organization (CDMO),...

4 months ago - GlobeNewsWire

Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024

DURHAM, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”),...

5 months ago - GlobeNewsWire

Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter

DURHAM, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), ...

5 months ago - GlobeNewsWire

Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility

Company poised to execute additional cGMP activities throughout the remainder of the year Company poised to execute additional cGMP activities throughout the remainder of the year

5 months ago - GlobeNewsWire

Scorpius Holdings Announces Reverse Stock Split

DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), ...

5 months ago - GlobeNewsWire

NYSE American to Commence Delisting Proceedings Against Scorpius Holdings, Inc. (SCPX)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of ...

6 months ago - Business Wire

Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024

DURHAM, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (‘Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), t...

7 months ago - GlobeNewsWire

Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility

DURHAM, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced a significant exp...

7 months ago - GlobeNewsWire

Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald

DURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), to...

8 months ago - GlobeNewsWire

Scorpius Holdings Provides 2023 Year-End Business Update; Reports 570% Sequential Increase in Revenue for the Fourth Quarter of 2023

DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (‘Scorpius” or “the Company”), an integrated contract development and manufacturing organization providing...

8 months ago - GlobeNewsWire

Scorpius Holdings Announces Receipt of Filing Delinquency Notification

Reaffirms commitment to regaining compliance with the NYSE American continued listing standards Reaffirms commitment to regaining compliance with the NYSE American continued listing standards

8 months ago - GlobeNewsWire

Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University

DURHAM, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced that it has bee...

9 months ago - GlobeNewsWire

Scorpius Holdings Accepted as a Member of the US Government's BioMaP-Consortium

Provides Access to Growth Funding and Enhanced Access to Federal Projects Provides Access to Growth Funding and Enhanced Access to Federal Projects

10 months ago - GlobeNewsWire

Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock

DURHAM, N.C., March 07, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), ...

10 months ago - GlobeNewsWire

Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023

Estimates Sequential Reduction in the Fourth Quarter of 2023 Operating Loss by  Over $3.3 Million or Approximately 30% Compared to the Third Quarter of 2023

10 months ago - GlobeNewsWire

NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today

DURHAM, N.C., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences / Scorpius Holdings, Inc.  (NYSE American: NHWK ; SCPX), an integrated contract development and manufacturing organization (CDMO),...

11 months ago - GlobeNewsWire